Significant correlation between electroretinogram parameters and ocular vascular endothelial growth factor concentration in central retinal vein occlusion eyes

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 5737-5742

  Yasuda, Shunsuke ^a   Kachi, Shu ^a   Kondo, Mineo ^a   Ushida, Hiroaki ^a   Uetani, Ruka ^a   Terui, Takayuki ^a   Piao, Chang Hua ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; VASCULOTROPIN; BIOLOGICAL MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

A WAVE; ADULT; AGED; AQUEOUS HUMOR; B WAVE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CORRELATION ANALYSIS; ELECTRORETINOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RETINA MACULA EDEMA; REVIEW; VISUAL ACUITY; ARTICLE; ELECTRORETINOGRAPHY; MEDICAL RECORD; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PREDICTIVE VALUE; RETINA VEIN OCCLUSION; RISK FACTOR; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; AQUEOUS HUMOR; BIOLOGICAL MARKERS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETINAL VEIN OCCLUSION; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 80053300528     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6923     Document Type: Review

References (37)

1. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
2. Pe'er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998;105:412-416.
3. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105: 232-237.
4. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486-491.
5. Karpe G. The basis of clinical electroretinography. Acta Ophthalmol Suppl. 1945;24:1-118.
6. Karpe G, Uchermann A. The clinical electroretinogram. VII. The electroretinogram in circulatory disturbances of the retina. Acta Ophthalmol. 1955;33:493-516.
7. Karpe G, Germanis M. The prognostic value of the electroretinogram in thrombosis of the retinal veins. Acta Ophthalmol. 1962;70:202-229.
8. Hayreh SS, Klugman MR, Podhajsky P, Kolder HE. Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities. Graefes Arch Clin Exp Ophthalmol. 1989;227:549-561.
9. Hayreh SS, Klugman MR, Beri M, Kimura AE, Podhajsky P. Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol. 1990;228:201-217.
10. Breton ME, Quinn GE, Keene SS, Dahmen JC, Brucker AJ. Electroretinogram parameters at presentation as predictors of rubeosis in central retinal vein occlusion patients. Ophthalmology. 1989;96: 1343-1352.
11. Breton ME, Montzka DP, Brucker AJ, Quinn GE. Electroretinogram interpretation in central retinal vein occlusion. Ophthalmology. 1991;98:1937-1944.
12. Breton ME, Schueller AW, Montzka DP. Electroretinogram bwave implicit time and b/a wave ratio as a function of intensity in central retinal vein occlusion. Ophthalmology. 1991;98: 1845-1853.
13. Johnson MA, Marcus S, Elman MJ, McPhee TJ. Neovascularization in central retinal vein occlusion. Electroretinographic findings. Arch Ophthalmol. 1988;106:348-352.
14. Johnson MA, McPhee TJ. Electroretinopraphic findings in iris neovascularization due to acute central retinal vein occlusion. Arch Ophthalmol. 1993;111:806-814.
15. Severns ML, Johnson MA. Predicting outcome in central retinal vein occlusion using the flicker electroretinogram. Arch Ophthalmol. 1993;111:1123-1130.
16. Kaye SB, Harding SP. Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis. Arch Ophthalmol. 1988;106:353-356.
17. Sabates R, Hirose T, McMeel JW. Electroretinography in the prognosis and classification of central retinal vein occlusion. Arch Ophthalmol. 1983;101:232-235.
18. Matsui Y, Katsumi O, Mehta MC, Hirose T. Correction of electroretinographic and fluorescein angiographic findings in unilateral central retinal vein obstruction. Graefes Arch Clin Exp Ophthalmol. 1994;232:449-457.
19. Morrell AJ, Thompson DA, Gibson JM, Kritzinger EE, Drasdo N. Electroretinography as a prognostic indicator of neovascularization in CRVO. Eye. 1991;5:362-368.
20. Matsui Y, Katsumi O, McMeel JW, Hirose T. Prognostic value of initial electroretinogram in central retinal vein obstruction. Graefes Arch Clin Exp Ophthalmol. 1994;232:75-81.
21. Larsson J, Andreasson S, Bauer B. Cone b-wave implicit time as an early predictor of rubeosis in central retinal vein occlusion. Am J Ophthalmol. 1998;125:247-249.
22. Larsson J, Bauer B, Andreasson S. The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion. Acta Ophthalmol Scand. 2000;78:187-190.
23. Larsson J, Andreasson S. Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion. Br J Ophthalmol. 2001;85:683-685.
24. Kjeka O, Bredrup C, Krohn J. Photopic 30 Hz flicker electroretinography predicts ocular neovascularization in central retinal vein occlusion. Acta Ophthalmol Scand. 2007;85:640-643.
25. Kuo HK, Kuo MT, Chen YJ, et al. The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248:185-189.
26. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
27. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26:279-284.
28. Kriechbaum K, Michels S, Prager F, et al. Intravitreal avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol. 2007;92:518-522.
29. Kondo M, Miyake Y, Kondo N, et al. Peripheral cone dystrophy: a variant of cone dystrophy with predominant dysfunction in the peripheral cone system. Ophthalmology. 2004;111:732-739.
30. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;5:1025-1032.
31. Campochiaro PA, Choy DF, Do DV, et al. Monitoring ocular drug therapy by analysis of aqueous samples. Ophthalmology. 2009;116:2158-2164.
32. Nonobe NI, Kachi S, Kondo M, et al. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab. Retina. 2009;29:579-585.
33. Glacet-Bernard A, Coscas G, Chabanel A, et al. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology. 1996;103:551-560.
34. Servais GE, Thompson HS, Hayreh SS. Relative afferent papillary defect in central retinal vein occlusion. Ophthalmology. 1986;93: 301-303.
35. PA Bloom, Papakostopoulos D, Gogolitsyn Y, et al. Clinical infrared pupillometry in central retinal vein occlusion. Br J Ophthalmol. 1993;77:75-80.
36. Matsuyama K, Ogata N, Jo N, Shima C, Matsuoka M, Matsumura M. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol. 2009;53:243-248.
37. Sakaue H, Katsumi O, Hirose T. Electroretinographic findings in fellow eyes of patients with central retinal vein occlusion. Arch Ophthalmol. 1989;107:1459-1462.